Study To Assess Radiofrequency Diathermocontraction Device For Muscle Stimulation And The Treatment Of Abdominal Fat

Inclusion Criteria: * A healthy male or female 18 years of age or older. * Agrees to be treated with the Brera/Med 400 device. * Understands and accepts obligation not to receive any other procedures on the treatment area through the length of the study. * Understands and accepts the obligation and is logistically able to be present for all visits. * Is willing to comply with all requirements of the study and sign the informed consent document. Exclusion Criteria: * Is pregnant or of childbearing potential and not using medically effective birth control, or has been pregnant in the last 3 months, currently breast feeding or planning a pregnancy during the study. * Is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within in the area to be treated 6 months (or at the discretion of the Investigator) prior to entering this study. * Has injured (such as a cut, wound) or infected skin, or has presence of evident pathologies such as melanomas or other tumors of the skin, dermatitis, eczema, psoriasis, etc. in the area to be treated. * Is on local, oral, or systemic anesthetic agents. * Has nerve insensitivity to heat in the treatment area. * Has received an organ transplant. * Has any embedded electronic device that gives or receives a signal, the device should be turned off or removed prior to treatment. * Has an embedded pacemaker or implantable cardioverter defibrillator (ICD), the client's cardiologist must be consulted prior to treatment. NOTE: This device has not been tested on patients implanted with electronic devices that receive or emit signals, such as: Pacemakers, Implantable Cardiac Defibrillators (ICD), or Cardiac Resynchronization Therapy (CRT) devices. * If the neutral pad would need to be placed on a subject that has a metal plate, rod, or any metal implant that could conduct heat. * Has an allergy to adhesives, such as glues on medical tape, they should be alerted that a rash may occur on the applicator and neutral pad site, and an over-the-counter solution may be used to treat the area. * Has an unhealthy expectation of the results - this is not plastic surgery and all subjects should be fully informed of the treatment's expected results. * Has severe laxity or sagging that causes redundant folds of tissue or hanging skin in the area to be treated - this treatment will be ineffective. * Has used Accutane (Isotretinoin) six to twelve months prior to treatment, as this can thin the skin and make it brittle. * Is currently taking anticoagulants. * The treatment area has scars and/or tattoos. * Has any of the following conditions: * Thrombosis or Thrombophlebitis * Active Vascular Disease * Labyrinthitis and Tinnitus * Liver Disease or Dyslipidemias * Acute Sepsis * Has any condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound study results or may interfere significantly with the subject's participation. Cautionary Criteria: • Has any of the following conditions: * Autoimmune Disease * Diabetic * Herpes Simplex